Sean P. Nolan
Director; Director, Chief Executive Officer · 2 filings · Latest: May 13, 2026
Taysha Gene Therapies, Inc.
Ventas, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TSHA | Sean P. Nolan | Director, Chief Executive Officer | Jan 26, 2026 | Sale | $4.61 | 41,312 | $190.4K | 2,908,257 | |
TSHA | Sean P. Nolan | Director, Chief Executive Officer | Jan 23, 2026 | Sale | $4.75 | 136,789 | $649.7K | 2,949,569 | |
TSHA | Sean P. Nolan | — | Jan 23, 2026 | Proposed Sale | $5.09 | 168,078 | $855.5K | — |